Showing results (171-180 of 190) with videos related to
Sort By:
Pageof 19
Progress in Cardiovascular Diseases|March 1, 1996
A summary and assessment of the findings and conclusions of the ESVEM trialJ W Mason, F I Marcus, J T Bigger, et al.The Journal of Clinical Endocrinology and Metabolism|May 1, 1993
Effects of acute tryptophan depletion on nocturnal melatonin secretion in humansR C Zimmermann, C J McDougle, M Schumacher, et al.Journal of the American College of Cardiology|February 1, 1983
Clinical factors predicting successful electrophysiologic-pharmacologic study in patients with ventricular tachycardiaC D Swerdlow, G Gong, D S Echt, et al.The New England Journal of Medicine|August 3, 1995
A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial InvestigatorsJ W Mason, J B O'Connell, A Herskowitz, et al.Circulation|April 1, 1978
Clinical electrophysiologic effects of tocainideJ L Anderson, J W Mason, R A Winkle, et al.International Journal of Cardiology|June 1, 1985
The mechanisms of ventricular tachycardia in humans determined by intraoperative recording of the electrical activation sequenceJ W Mason, E B Stinson, P E Oyer, et al.European Heart Journal|December 1, 1995
The Myocarditis Treatment Trial: design, methods and patients enrollmentE A Hahn, V L Hartz, T E Moon, et al.Circulation|June 1, 1982
Surgery for ventricular tachycardia: efficacy of left ventricular aneurysm resection compared with operation guided by electrical activation mappingJ W Mason, E B Stinson, R A Winkle, et al.Acta Psychiatrica Scandinavica|September 1, 1988
Relationship of age to TSH response to TRH in depressed menV S Wahby, G A Ibrahim, E L Giller, et al.American Heart Journal|April 1, 1982
Programmed ventricular stimulation in predicting vulnerability to ventricular arrhythmias and their response to antiarrhythmic therapyJ W Mason, C D Swerdlow, R A Winkle, et al.Pageof 19